The 6 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 19.50, with a high estimate of 22.00 and a low estimate of 11.00. The median estimate represents a +222.58% increase from the last price of 6.05.
The current consensus among 7 polled investment analysts is to Buy stock in aTyr Pharma Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.28
Reporting Date Mar 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.